Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbu Dhabi Health Services Company
About this trial
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Eligibility criteria
Qualifiers
Age more than 18.
STEMI complicated by cardiogenic shock.
Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
Patient admitted between January 2019 to March 2024.
Disqualifiers
Age less than 18.
Shock patient not related to Myocardial infarction.
NSTEMI-related cardiogenic shock.
Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 1 trial groupSponsors and collaborators
Abu Dhabi Health Services Company
Lead sponsor
Sheikh Shakhbout Medical City
Collaborator
Sheikh Khalifa Medical City
Collaborator
Source ClinicalTrials.gov